234 related articles for article (PubMed ID: 1719382)
1. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
[TBL] [Abstract][Full Text] [Related]
2. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
Martel C; Trudel C; Couet J; Labrie C; BĂ©langer A; Labrie F
Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
Dadras SS; Cai X; Abasolo I; Wang Z
Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
[TBL] [Abstract][Full Text] [Related]
4. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
Kelce WR; Lambright CR; Gray LE; Roberts KP
Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate.
Labrie C; Simard J; Zhao HF; Belanger A; Pelletier G; Labrie F
Endocrinology; 1989 Jun; 124(6):2745-54. PubMed ID: 2524377
[TBL] [Abstract][Full Text] [Related]
6. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate.
Shao TC; Kong A; Cunningham GR
Prostate; 1994 Apr; 24(4):212-20. PubMed ID: 7511803
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment.
Astancolle S; Guidetti G; Pinna C; Corti A; Bettuzzi S
J Endocrinol; 2000 Nov; 167(2):197-204. PubMed ID: 11054633
[TBL] [Abstract][Full Text] [Related]
8. Effects of finasteride on the rat ventral prostate.
Shao TC; Kong A; Marafelia P; Cunningham GR
J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
[TBL] [Abstract][Full Text] [Related]
9. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
Ghusn HF; Shao TC; Klima M; Cunningham GR
J Androl; 1991; 12(5):315-22. PubMed ID: 1765567
[TBL] [Abstract][Full Text] [Related]
10. Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment.
Avila DM; Fuqua SA; George FW; McPhaul MJ
J Endocrinol; 1998 Dec; 159(3):403-11. PubMed ID: 9834458
[TBL] [Abstract][Full Text] [Related]
11. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Geller J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
[TBL] [Abstract][Full Text] [Related]
12. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
Labrie C; Trudel C; Li S; Martel C; CouĂȘt J; Labrie F
Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
[TBL] [Abstract][Full Text] [Related]
13. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
Fleshner NE; Trachtenberg J
J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
[TBL] [Abstract][Full Text] [Related]
14. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
[TBL] [Abstract][Full Text] [Related]
15. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
Geller J; Sionit L
J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893
[TBL] [Abstract][Full Text] [Related]
16. TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
Russo P; Warner JA; Huryk R; Perez G; Heston WD
Prostate; 1994 May; 24(5):237-43. PubMed ID: 8170836
[TBL] [Abstract][Full Text] [Related]
17. Anti-androgen effects of the aromatase inhibitor, atamestane.
Shao TC; Marcelli M; Kong A; Cunningham GR
J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
19. Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.
George FW; Russell DW; Wilson JD
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8044-7. PubMed ID: 1654556
[TBL] [Abstract][Full Text] [Related]
20. Modulation of gene expression by androgen and oestrogens in the testis and prostate of the adult rat following androgen withdrawal.
Turner KJ; Morley M; MacPherson S; Millar MR; Wilson JA; Sharpe RM; Saunders PT
Mol Cell Endocrinol; 2001 Jun; 178(1-2):73-87. PubMed ID: 11403897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]